University of Maryland, Baltimore County, Baltimore, MD.
University of California, Irvine, Irvine, CA.
AMIA Annu Symp Proc. 2023 Apr 29;2022:942-951. eCollection 2022.
The objective of this study was to investigate the state of the interoperable mobile health application (app) ecosystem at the start of the 21st Century Cures Act to understand the opportunities currently available to patients for accessing and using their computable clinical data. Thus, we sought to identify third-party apps in the Apple App and Google Play Stores that seem to be capable of automatically downloading clinical data via a FHIR-based application programming interface through a targeted review of health apps. We found that few of the apps in this review have this capability (1.4% of 1,272 iOS apps and 0.6% of 1,449 Android apps). Ultimately, our results suggest that this is a nascent marketspace. If barriers to app development are not identified and addressed, and efforts are not made to educate patients and improve discoverability of apps, it could mean that patients will not benefit from these interoperability measures.
本研究旨在调查 21 世纪治疗法案(21st Century Cures Act)启动之初可互操作的移动医疗应用程序(app)生态系统的现状,以了解患者目前可访问和使用其可计算临床数据的机会。因此,我们试图通过对健康应用程序的有针对性审查,在苹果应用商店(Apple App Store)和谷歌应用商店(Google Play Store)中确定似乎能够通过基于 FHIR 的应用程序编程接口自动下载临床数据的第三方应用程序。我们发现,本审查中的应用程序很少具有此功能(在 1272 个 iOS 应用程序中占 1.4%,在 1449 个 Android 应用程序中占 0.6%)。最终,我们的研究结果表明,这是一个新兴的市场空间。如果不发现和解决应用程序开发的障碍,并且不努力教育患者并提高应用程序的可发现性,那么这可能意味着患者将无法从这些互操作性措施中受益。